Catharina C Gross Selected Research

Catharina C Gross Research Topics

Disease

24	Multiple Sclerosis 01/2023 - 07/2013
12	Relapsing-Remitting Multiple Sclerosis 11/2021 - 06/2015
5	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023 - 01/2015
5	Autoimmune Diseases (Autoimmune Disease) 12/2022 - 03/2013
4	Disease Progression 03/2024 - 07/2013
4	Neuroinflammatory Diseases 01/2023 - 01/2016
4	Autoimmune Diseases of the Nervous System 01/2023 - 07/2017
3	Inflammation (Inflammations) 01/2022 - 01/2021
3	Central Nervous System Diseases (CNS Diseases) 01/2022 - 07/2012
3	Neoplasms (Cancer) 07/2018 - 01/2018
2	Susac Syndrome 01/2024 - 12/2016
2	Epilepsy (Aura) 01/2023 - 11/2019
2	Myasthenia Gravis 01/2023 - 12/2022
2	HIV Infections (HIV Infection) 10/2020 - 09/2015
2	Lymphoma (Lymphomas) 12/2019 - 01/2018
2	Cognitive Dysfunction 11/2019 - 01/2017
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 11/2017 - 07/2017
2	Cerebellar Ataxia (Dysmetria) 01/2017 - 07/2012
1	Fatigue 05/2023
1	Isaacs Syndrome (Neuromyotonia) 01/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2023
1	Ataxia (Dyssynergia) 01/2023
1	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Narcolepsy 01/2023
1	Epstein-Barr Virus Infections 11/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	COVID-19 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Infections 01/2022
1	Autoimmune limbic encephalitis 12/2021
1	Demyelinating Diseases (Demyelinating Disease) 12/2021
1	Psychotic Disorders (Schizoaffective Disorder) 12/2021
1	Glioma (Gliomas) 11/2021
1	Progressive Multifocal Leukoencephalopathy 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021
1	Hippocampal Sclerosis 10/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Sinusitis 01/2020
1	Otitis 01/2020
1	Yellow Fever 11/2019
1	Liver Failure 01/2019
1	Vitiligo 12/2018

Drug/Important Bio-Agent (IBA)

12	AntibodiesIBA 12/2022 - 07/2012
8	Alemtuzumab (Campath)FDA Link 01/2022 - 03/2016
7	Natalizumab (Tysabri)FDA Link 01/2023 - 06/2015
6	AutoantibodiesIBA 01/2023 - 01/2017
4	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2015
4	Fingolimod Hydrochloride (FTY720)FDA Link 11/2019 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2021
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2023 - 10/2020
3	CytokinesIBA 01/2022 - 02/2015
3	Dimethyl FumarateIBA 11/2021 - 02/2016
3	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 01/2015
2	InterferonsIBA 03/2024 - 12/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 12/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 11/2016
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2023 - 11/2016
2	Cholinergic ReceptorsIBA 01/2023 - 12/2022
2	N-acetyltalosaminuronic acid (NAT)IBA 01/2023 - 01/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2022 - 11/2022
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 07/2017
2	Daclizumab (Zenapax)FDA Link 01/2019 - 07/2013
2	Immunoglobulins (Immunoglobulin)IBA 07/2018 - 01/2018
2	AntigensIBA 07/2018 - 03/2013
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2018
2	EnzymesIBA 11/2016 - 01/2015
1	IronIBA 01/2024
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2023
1	GelatinasesIBA 01/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	Cladribine FDA LinkGeneric 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Complement C5 (Complement 5)IBA 01/2023
1	Cell Adhesion MoleculesIBA 01/2023
1	Integrin alpha4beta1 (VLA-4)IBA 11/2022
1	Tryptophan (L-Tryptophan)FDA Link 09/2022
1	Methylprednisolone FDA LinkGeneric 09/2022
1	SteroidsIBA 09/2022
1	dimemorfan (AT 17)IBA 01/2022
1	Oligoclonal BandsIBA 01/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 12/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	Leucine (L-Leucine)FDA Link 11/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Linoleic Acid (Linoleate)IBA 01/2021
1	Conjugated Linoleic AcidsIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	IgG Receptors (Fc gamma RI)IBA 12/2019
1	LigandsIBA 11/2019
1	teriflunomideIBA 01/2019
1	Plasma KallikreinIBA 01/2019
1	BradykininIBA 01/2019
1	N 30IBA 12/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018

Therapy/Procedure

10	Therapeutics 03/2024 - 07/2015
3	Immunotherapy 01/2023 - 11/2017
1	Aftercare (After-Treatment) 12/2018